Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,107 Cr
down ₹83.2 Cr vs Jul 2025
- Stocks held
- 29
- unchanged
- Top 10 weight
- 62.1%
- of the portfolio in its ten largest
- Cash & debt
- 2.2%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 8, trimmed 21
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In August 2025 it disclosed 29 stocks worth ₹3,107 Cr, down ₹83.2 Cr from Jul 2025. Its largest positions were Cipla Limited (9.2%), Sun Pharmaceutical Industries Limited (7.9%), IPCA Laboratories Limited (7.6%); the ten largest together made up 62.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.3% of its equity. Cash and debt stood at 2.2%. Compared with Jul 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
32%
Holds more cash than 32% of peers
Holdings in August 2025
Download CSVEvery line the fund disclosed, with the change against Jul 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 9.16%
- Δ weight
- up 0.43 pts
- Value
- ₹285 Cr
- Δ value
- up ₹6.2 Cr
- Status
- Added
- Weight
- 7.88%
- Δ weight
- down 0.33 pts
- Value
- ₹245 Cr
- Δ value
- down ₹17.2 Cr
- Status
- Trimmed
- Weight
- 7.56%
- Δ weight
- down 0.28 pts
- Value
- ₹235 Cr
- Δ value
- down ₹15.2 Cr
- Status
- Trimmed
- Weight
- 7.38%
- Δ weight
- down 0.42 pts
- Value
- ₹229 Cr
- Δ value
- down ₹19.4 Cr
- Status
- Trimmed
- Weight
- 6.12%
- Δ weight
- up 0.04 pts
- Value
- ₹190 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 5.55%
- Δ weight
- down 0.41 pts
- Value
- ₹172 Cr
- Δ value
- down ₹17.8 Cr
- Status
- Trimmed
- Weight
- 4.77%
- Δ weight
- up 0.19 pts
- Value
- ₹148 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 4.66%
- Δ weight
- up 0.77 pts
- Value
- ₹145 Cr
- Δ value
- up ₹20.8 Cr
- Status
- Added
- Weight
- 4.53%
- Δ weight
- up 0.01 pts
- Value
- ₹141 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 4.52%
- Δ weight
- up 0.20 pts
- Value
- ₹140 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 4.31%
- Δ weight
- down 0.07 pts
- Value
- ₹134 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 3.37%
- Δ weight
- up 0.14 pts
- Value
- ₹105 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 3.33%
- Δ weight
- up 0.06 pts
- Value
- ₹103 Cr
- Δ value
- down ₹77 L
- Status
- Trimmed
- Weight
- 3.27%
- Δ weight
- up 0.32 pts
- Value
- ₹101 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 3.03%
- Δ weight
- down 0.12 pts
- Value
- ₹94.3 Cr
- Δ value
- down ₹6.3 Cr
- Status
- Trimmed
- Weight
- 2.77%
- Δ weight
- down 0.45 pts
- Value
- ₹86.2 Cr
- Δ value
- down ₹16.6 Cr
- Status
- Trimmed
- Weight
- 2.65%
- Δ weight
- down 0.06 pts
- Value
- ₹82.4 Cr
- Δ value
- down ₹4.2 Cr
- Status
- Trimmed
- Weight
- 2.51%
- Δ weight
- up 0.03 pts
- Value
- ₹78 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 2.23%
- Δ weight
- up 0.39 pts
- Value
- ₹69.2 Cr
- Δ value
- up ₹10.6 Cr
- Status
- Added
- Weight
- 1.76%
- Δ weight
- up 0.03 pts
- Value
- ₹54.8 Cr
- Δ value
- down ₹64 L
- Status
- Trimmed
- Weight
- 1.43%
- Δ weight
- down 0.03 pts
- Value
- ₹44.4 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 1.38%
- Δ weight
- down 0.28 pts
- Value
- ₹42.9 Cr
- Δ value
- down ₹10.2 Cr
- Status
- Trimmed
- Weight
- 1.29%
- Δ weight
- down 0.07 pts
- Value
- ₹40 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 1.19%
- Δ weight
- up 0.09 pts
- Value
- ₹36.8 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 0.75%
- Δ weight
- down 0.20 pts
- Value
- ₹23.2 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 0.64%
- Δ weight
- up 0.05 pts
- Value
- ₹19.8 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.64%
- Δ weight
- up 0.05 pts
- Value
- ₹19.8 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 0.52%
- Δ weight
- down 0.04 pts
- Value
- ₹16.2 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- up 0.01 pts
- Value
- ₹13.3 Cr
- Δ value
- down ₹18 L
- Status
- Trimmed
- Weight
- 0.31%
- Δ weight
- down 0.06 pts
- Value
- ₹9.6 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 0.08%
- Δ weight
- down <0.01 pts
- Value
- ₹2.5 Cr
- Δ value
- down ₹10 L
- Status
- Trimmed
What changed, Jul 2025 to Aug 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Globus Medical Incup ₹20.8 Cr (+0.77% pts)
- Procter & Gamble Health Limitedup ₹7.6 Cr (+0.32% pts)
- Cipla Limitedup ₹6.2 Cr (+0.43% pts)
- Sai Life Sciences Limitedup ₹2.8 Cr (+0.20% pts)
- Apollo Hospitals Enterprise Limitedup ₹2.2 Cr (+0.19% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2025, the weight rose most in Healthcare Equipment & Supplies (+0.8 pts) and Healthcare Services (+0.1 pts), and fell most in Pharmaceuticals (−0.6 pts) and Pharmaceuticals & Biotechnology (−0.2 pts).
- Healthcare Equipment & Supplies6.9% → 7.7%+0.8 pts
- Healthcare Services17.4% → 17.5%+0.1 pts
- Pharmaceuticals6.1% → 5.5%−0.6 pts
- Pharmaceuticals & Biotechnology67.5% → 67.3%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2022 | Aug 2024 | Feb 2025 | May 2025 | Jul 2025 | Aug 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 56.9% | 67.9% | 65.2% | 66.9% | 67.5% | 67.3% |
| Healthcare Services | 26.0% | 15.9% | 17.5% | 17.2% | 17.4% | 17.5% |
| Healthcare Equipment & Supplies | 5.5% | 8.3% | 10.1% | 8.0% | 6.9% | 7.7% |
| Pharmaceuticals | 7.6% | 5.6% | 5.3% | 5.7% | 6.1% | 5.5% |
| Insurance | 2.7% | 1.9% | 1.4% | 1.5% | 1.5% | 1.5% |
| Retailing | 1.2% | 0.5% | 0.5% | 0.6% | 0.6% | 0.5% |
Allocation in Aug 2025change vs Jul 2025
- Pharmaceuticals & Biotechnology (14)67.3%▼ 0.2 pts
- Healthcare Services (7)17.5%▲ 0.1 pts
- Healthcare Equipment & Supplies (3)7.7%▲ 0.8 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2025
2.2%
▲ 0.4 pts vs Jul 2025
- Cash alone
- 2.2%
- cash and net receivables
- A year earlier
- 5.6%
- Aug 2024 · now ▼ 3.4 pts
- Last 12 months
- 0.1% – 4.8%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.